about
Mash1 efficiently reprograms rat astrocytes into neurons.The human gastrointestinal tract, a potential autologous neural stem cell sourceStem cell therapy: medico-legal perspectives in ItalyModeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisThe preclinical discovery of amyotrophic lateral sclerosis drugs.Treating non-motor symptoms of Parkinson's disease with transplantation of stem cellsSpecimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consentTransplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease.Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives.Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons.Standard recommendations for the application of Chinese clinical cell therapy for neurorestoration (2012).Genetic correction of stem cells in the treatment of inherited diseases and focus on xeroderma pigmentosum.An update on potential therapeutic strategies for Parkinson's disease based on pathogenic mechanisms.Integrating Patient Concerns into Parkinson's Disease Management.Tracing synaptic connectivity onto embryonic stem cell-derived neurons.Direct differentiation of adult ocular progenitors into striatal dopaminergic neurons.Polysaccharide nanofibers with variable compliance for directing cell fate.Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1.Labeling of cynomolgus monkey bone marrow-derived mesenchymal stem cells for cell tracking by multimodality imaging.Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).
P2860
Q34096351-42E2CFCA-F681-404D-98DA-5EACDED82052Q34984166-410B7E01-E483-496D-9E73-CDDB49AC4072Q35796574-6588E821-7C2C-44FD-95A9-2C3603124DCAQ35921136-2AE32EA0-D39E-468B-8410-B6A98FB4BEC1Q36009915-6BCBDD99-E5D1-43EC-AF86-C4C62A639868Q36790753-D1272797-3A34-4B0D-9B71-622860A72B34Q36861555-EA6FD683-4B14-4144-AF64-445AA229D976Q37296236-71E8E3A4-EB10-497A-96A9-FF2DDD7BC86BQ38050228-B677B5C6-CAD5-47D4-99CE-7C64CF4DAF74Q38069573-501615CB-D955-4419-854E-B2929D37383DQ38138589-72F6C4F4-1896-45EB-B444-4A15CD7AE553Q38151436-5B4DAACF-16C3-4E4B-944D-552B4719E2B0Q38823785-7455721C-73F1-4C45-A7CB-C0E81FDC131EQ39094808-EDF3F2F6-F4EA-49E9-B966-E84285312E3AQ39274532-5F10445E-A7CA-4F28-BFC0-281FE8AA0DDAQ41154991-6C3D0E3C-832A-450A-82A9-71EC6DB7DC9AQ47872679-742C03A2-1C56-4D8A-BB8D-4939815A11D2Q48710371-196CA4FB-A150-4C97-A93C-371B1240C9DEQ50667798-56ABEFFF-75CE-4348-9B2D-93086AACEA8BQ52594563-F3ED270F-4D8F-4422-AEEC-C66FF72F53E4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell-based therapies for Parkinson's disease.
@en
Cell-based therapies for Parkinson's disease.
@nl
type
label
Cell-based therapies for Parkinson's disease.
@en
Cell-based therapies for Parkinson's disease.
@nl
prefLabel
Cell-based therapies for Parkinson's disease.
@en
Cell-based therapies for Parkinson's disease.
@nl
P2860
P356
P1476
Cell-based therapies for Parkinson's disease.
@en
P2093
Sean C Dyson
P2860
P304
P356
10.1586/ERN.11.33
P577
2011-06-01T00:00:00Z